RAD - Rite Aid Corporation

NYSE - Nasdaq Real Time Price. Currency in USD
2.12
+0.10 (+4.70%)
At close: 3:59PM EDT

2.11 -0.01 (-0.24%)
After hours: 4:01PM EDT

Stock chart is not supported by your current browser
Previous Close2.02
Open2.02
Bid2.10 x 301500
Ask2.11 x 45100
Day's Range2.01 - 2.12
52 Week Range1.38 - 4.21
Volume27,196,242
Avg. Volume12,756,982
Market Cap2.232B
Beta1.86
PE Ratio (TTM)2.35
EPS (TTM)0.90
Earnings DateJun 27, 2018
Forward Dividend & YieldN/A (N/A)
Ex-Dividend Date1999-10-14
1y Target Est2.00
Trade prices are not sourced from all markets
  • What’s behind Rite Aid’s Deteriorating Margins?
    Market Realist3 hours ago

    What’s behind Rite Aid’s Deteriorating Margins?

    Rite Aid (RAD) is expected to post adjusted loss of one cent per share when it reports first-quarter 2019 results on June 27 in comparison to an adjusted loss of five cents per share in the same quarter last year. Rite Aid has witnessed a continuous deterioration in its profitability over the years. Rite Aid has weaker margins than other major drug stores.

  • InvestorPlace4 hours ago

    There’s More Riding on Prime Day Than You Think for Amazon.com Stock

    Amazon Prime Day arrives next month and it could be a big one for Amazon.com, Inc. (NASDAQ:AMZN) stock. Last year’s Prime Day actually forecast a bit of a top for Amazon stock. Q3 results in late October would catalyze a massive run in Amazon stock, which now has risen 77%.

  • What Are Rite Aid’s Key Revenue Drivers?
    Market Realist5 hours ago

    What Are Rite Aid’s Key Revenue Drivers?

    Rite Aid (RAD), which will report fiscal first quarter 2019 results on June 27, is projected to report a 31.6% YoY (year-over-year) decline in total sales to $5.3 billion. Rite Aid’s total sales from continuing operations declined 6.1% YoY to $21.5 billion during the fiscal year ended March 3, 2018.

  • What to Expect from Rite Aid’s Q1 2019 Results
    Market Realist7 hours ago

    What to Expect from Rite Aid’s Q1 2019 Results

    Rite Aid (RAD) is slated to report results for the fiscal first quarter of 2019 on June 27. Read part two and three of this series to learn about Rite Aid’s recent financial performance and part four to know about the expectations for the coming quarter. Rite Aid is the third-largest pharmacy retail chain in the US.

  • ACCESSWIRE8 hours ago

    Today's Research Reports on Stocks to Watch: Rite Aid and CarMax

    NEW YORK, NY / ACCESSWIRE / June 25, 2018 / Rite Aid saw slight gains on high volume in Friday's trading session after announcing a special shareholder meeting for August that will vote on the proposed merger with Albertsons. Shares of CarMax also blew up in the session after announcing impressive first quarter results that beat on both the top and the bottom line. The company announced a meeting date of August 9, 2018, for a special meeting of stockholders of record as of June 22, 2018 to, among other things, consider and vote on the proposed merger with Albertsons.

  • Walgreens Stock Looking Healthier Now That It’s in the Dow
    InvestorPlace4 days ago

    Walgreens Stock Looking Healthier Now That It’s in the Dow

    On Tuesday after the close, Wall Street found out that Walgreens (NASDAQ:WBA) would be joining the Dow Jones Industrial Average. It quickly propelled WBA stock higher, up more than 5% on Wednesday as a result. GE’s presence in the Dow, an index that was started more than 120 years ago in 1896 when it had just 12 names in it, had been bumpy in the early years.

  • Business Wire4 days ago

    Rite Aid Schedules Special Stockholder Meeting for August 9, 2018 to Vote on the Proposed Merger with Albertsons

    Rite Aid Corporation (RAD) (“Rite Aid”), announced today that it has established a meeting date of August 9, 2018, for a special meeting of stockholders of record as of June 22, 2018 to, among other things, consider and vote on a proposal to approve the previously announced Agreement and Plan of Merger, dated as of February 18, 2018 (the “Merger Agreement”), with Albertsons Companies, Inc. The special meeting of stockholders will take place at 8:30 a.m. Eastern Time at the office of Skadden, Arps, Slate, Meagher & Flom LLP, 4 Times Square, New York, NY 10036. Rite Aid stockholders as of the close of business on the record date for the special meeting will be entitled to receive notice of, and to vote at, the special meeting.

  • Wall Street Sees 20% Upside for Walgreens Stock
    Market Realist4 days ago

    Wall Street Sees 20% Upside for Walgreens Stock

    Can Walgreens Exceed Analyst Expectations for Fiscal Q3 2018? Walgreens stock has witnessed high levels of volatility over the past year. The pharmacy giant, which is currently trading at $68 as of June 20, has been in the range of $61.56 and $83.89 over the last-12-month period.

  • Why Walgreens Stock Rose 5% Yesterday
    Market Realist4 days ago

    Why Walgreens Stock Rose 5% Yesterday

    Walgreens Boots Alliance’s (WBA) stock gained 5.2% yesterday after the S&P Dow Jones Indexes announced that Walgreens would replace General Electric (GE) in the Dow Jones Industrial Average Index starting June 26. The news reduced Walgreens’s YTD losses from 11% to just about 6%.

  • Can Rite Aid's (RAD) Strategies Reverse Earnings Trend in Q1?
    Zacks5 days ago

    Can Rite Aid's (RAD) Strategies Reverse Earnings Trend in Q1?

    Rite Aid's (RAD) prospects look bright, owing to the pending acquisition, solid fiscal 2019 outlook and other strategies. But we remain skeptical about near-term results due to its dismal past trends.

  • Moody's6 days ago

    Wachovia Bank Commercial Mortgage Trust 2003-C6 -- Moody's Affirms One Interest Only Class of WBCMT 2003-C6

    Moody's rating action reflects a base expected loss of 4.5% of the current balance, compared to 22.3% at Moody's last review. For provisional ratings, this announcement provides certain regulatory disclosures in relation to the provisional rating assigned, and in relation to a definitive rating that may be assigned subsequent to the final issuance of the debt, in each case where the transaction structure and terms have not changed prior to the assignment of the definitive rating in a manner that would have affected the rating.

  • Business Wire6 days ago

    Health Dialog Joins Clinical, Business and Government Leaders to Discuss Best Practices for Patient Engagement Success

    Health Dialog, a leading provider of integrated population health management solutions for health plans, risk-bearing providers and self-insured employers, will assemble a panel of experts representing clinical, business and government perspectives to discuss patient engagement strategies that successfully educate and empower patients to take a more active role in their healthcare.

  • Business Wire7 days ago

    Rite Aid to Release First Quarter Results on June 27

    Rite Aid Corporation said today that it will release financial results for its Fiscal 2019 First Quarter, which ended June 2, 2018, on Wednesday, June 27, 2018. The company will hold an analyst call at 5 p.m.

  • ACCESSWIRE13 days ago

    Stock Performance Review on Rite Aid and Three Other Services Stocks

    Gains were broad based as seven out of nine sectors finished the trading session in green. WallStEquities.com has initiated research reports on the following Services stocks: GNC Holdings Inc. (NYSE: GNC), Rite Aid Corp. (NYSE: RAD), Walgreens Boots Alliance Inc. (NASDAQ: WBA), and AmerisourceBergen Corp. (NYSE: ABC).

  • Is It The Right Time To Buy Rite Aid Corporation (NYSE:RAD)?
    Simply Wall St.15 days ago

    Is It The Right Time To Buy Rite Aid Corporation (NYSE:RAD)?

    Rite Aid Corporation (NYSE:RAD), a consumer retailing company based in United States, saw a double-digit share price rise of over 10% in the past couple of months on the NYSE.Read More...

  • ACCESSWIRE19 days ago

    Today's Research Reports on Trending Tickers: CVS Health and Rite Aid

    NEW YORK, NY / ACCESSWIRE / June 6, 2018 / Major indexes closed mostly higher Tuesday, lifted by a rally from the technology sector. The Dow Jones Industrial Average decreased 0.06 percent to close at ...

  • Moody's24 days ago

    J.P. Morgan Commercial Mortgage Finance Corp. 2000-C10 -- Moody's Affirms Two Classes of JPMC 2000-C10

    The rating on the P&I class G was affirmed because the rating is consistent with Moody's expected loss plus realized losses. The rating on the IO class X was affirmed based on the credit quality of the referenced classes.

  • Business Wire24 days ago

    Rite Aid Announces New In-Store Safe Medication Disposal Program

    Rite Aid Corporation (RAD) announced today that it plans to install 100 medication disposal units in select pharmacies over the next year, the latest measure being taken by Rite Aid as part of its comprehensive strategy to address drug abuse and misuse in the country. The units offer individuals a free, safe and convenient way to dispose of expired or unwanted prescription and over-the-counter medications, helping to reduce the chances of accidental or intentional misuse. Rite Aid President and Chief Operating Officer Kermit Crawford will join U.S. Congressman Scott Perry to officially unveil the Company’s first in-store medication disposal unit at a press conference today at 10 a.m. at the Rite Aid Pharmacy located at 1137 Market Street in Lemoyne, Pa.

  • MarketWatch25 days ago

    Walgreens may be building the store of the future in Florida — but Wall Street is skeptical

    CVS Health Corp. is buying Aetna Inc., while Cigna Corp. is snapping up Express Scripts Holding Co. As health-care companies vertically integrate with high-priced deals across varied parts of the industry’s supply chain, Walgreens Boots Alliance Inc.(WBA) , its acquisition of rival Rite Aid’s (RAD)nearly 2,000 stores now complete, remains alone at the party. See: U.S. health care is changing in a big way.

  • Analyzing CVS Health and Walgreens’ Acquisitions
    Market Realist26 days ago

    Analyzing CVS Health and Walgreens’ Acquisitions

    Recent efforts to expand their footprints have impacted Walgreens (WBA) and CVS Health’s (CVS) share prices. CVS has faced investors’ skepticism about its plans to acquire Aetna.